COST-EFFECTIVENESS OF THE PNEUMOCOCCAL CONJUGATE VACCINE 10 VERSUS 13 ON PNEUMOCOCCAL DISEASE IN CHILDREN IN SWEDEN

被引：0
|
作者：
Peeters, E. [1 ]
Marijam, A. [2 ]
Chevalier, P. [1 ]
Ene, J. [3 ]
Folkesson, J. [3 ]
Izurieta, P. [2 ]
Joost, S. [4 ]
Urbonas, G. [5 ]
Adbelghany, M. [6 ]
机构：
[1] IQVIA, Zaventem, Belgium
[2] GSK, Wavre, Belgium
[3] IQVIA, Solna, Sweden
[4] GSK, Amersfoort, UT, Netherlands
[5] GSK, Warsaw, Poland
[6] GSK, Cairo, Egypt
来源：
VALUE IN HEALTH | 2022年 / 25卷 / 12期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
EE166
引用
收藏
页码：S85 / S85
页数：1
相关论文
共 50 条
  • [21] The Cost-Effectiveness of 13-Valent Pneumococcal Conjugate Vaccine in Seven Chinese Cities
    Li, Yan
    Wang, Huaqing
    Furnback, Wesley
    Wang, Bruce C. M.
    Zhu, Shuiqing
    Dong, Peng
    VACCINES, 2021, 9 (11)
  • [22] Potential Cost-Effectiveness of Pneumococcal Conjugate Vaccine (PCV) in Turkey
    Turel, Ozden
    Kisa, Adnan
    McIntosh, E. David G.
    Bakir, Mustafa
    VALUE IN HEALTH, 2013, 16 (05) : 755 - 759
  • [23] Cost-effectiveness of 13-valent pneumococcal conjugate vaccine: Germany, Greece, and The Netherlands
    Strutton, David R.
    Farkouh, Raymond A.
    Earnshaw, Stephanie R.
    Hwang, Sharon
    Theidel, Ulrike
    Kontodimas, Stathis
    Klok, Rogier
    Papanicolaou, Sotiria
    JOURNAL OF INFECTION, 2012, 64 (01) : 54 - 67
  • [24] Cost-Effectiveness of 13-Valent Pneumococcal Conjugate Vaccine Among Adults in the Philippines
    Santiaguel, Joel
    Averin, Ahuva
    Nua, Winniefer
    Atwood, Mark
    Huang, Liping
    Hariharan, Dhwani
    Guerrero, Josephine
    Zotomayor, Ricardo
    David-Wang, Aileen
    VALUE IN HEALTH REGIONAL ISSUES, 2025, 47
  • [25] Cost-effectiveness of Adult Vaccination Strategies Using Pneumococcal Conjugate Vaccine Compared With Pneumococcal Polysaccharide Vaccine
    Smith, Kenneth J.
    Wateska, Angela R.
    Nowalk, Mary Patricia
    Raymund, Mahlon
    Nuorti, J. Pekka
    Zimmerman, Richard K.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2012, 307 (08): : 804 - 812
  • [26] Pneumococcal penicillin resistance and the cost-effectiveness of pneumococcal vaccine
    Herman, CM
    Chen, J
    High, KP
    INFECTIONS IN MEDICINE, 1998, 15 (04) : 233 - +
  • [27] Effectiveness of the 13-Valent Pneumococcal Conjugate Vaccine on Invasive Pneumococcal Disease in Greenland
    Nikolova, Kristiana Alexandrova
    Andersson, Mikael
    Slotved, Hans-Christian
    Koch, Anders
    VACCINES, 2021, 9 (10)
  • [28] Cost-effectiveness of the 13-valent pneumococcal conjugate vaccine compared to the 10-valent vaccine in children: predictive analysis in the Ecuadorian context
    Bolanos-Diaz, Rafael
    Mino-Leon, Greta
    Zea, Eduardo
    JOURNAL OF PHARMACEUTICAL HEALTH SERVICES RESEARCH, 2022, 13 (04) : 341 - 350
  • [29] Cost-effectiveness analysis of 13-valent pneumococcal conjugate vaccine versus 23-valent pneumococcal polysaccharide vaccine in an adult population in South Korea
    Choi, Min-Joo
    Kang, Shin-On
    Oh, Jin-Jeong
    Park, Seong-Beom
    Kim, Min-Ja
    Cheong, Hee-Jin
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2018, 14 (08) : 1914 - 1922
  • [30] Cost-Effectiveness of the Pneumococcal Conjugate Vaccine (10- or 13-Valent) Versus No Vaccination for a National Immunization Program in Tunisia or Algeria
    Sarah J. Pugh
    Mark A. Fletcher
    Apostolos Charos
    Lynda Imekraz
    Matt Wasserman
    Raymond Farkouh
    Infectious Diseases and Therapy, 2019, 8 : 63 - 74
12345